Cell therapy is the rapidly growing segment of regenerative medicine. Both immune cell therapy and stem cell therapy make up the cell therapy market. It has been estimated that the global stem cell therapy market will generate a significant amount of revenue by 2030. The growth of stem cells market is further fuelled by the stupendous success of stem cell treatments in treating chronic diseases such as heart diseases, cancer, and neuromuscular diseases. Increasing funds from private as well as government, rising focus on stem cell research, and high amount of research on stem cell therapies by various organizations is stimulating the growth of this market.
Factors such as rising awareness towards R&D on stem cells, funding from government and private organizations, and rising awareness towards stem cell therapies is spurring the growth of global market. There is an increased funding for novel stem cell lines, approvals of clinical trials for stem cell therapy, and development of advanced genomic methods is further propelling the growth of this market. Also, in the emerging markets, there is an increased focus towards stem cell researches, evolution of new stem cell therapies and development of induced pluripotent stem cells as an alternative to ESCs, is thereby giving rise to new opportunities of growth in this market.
Moral issues pertaining to embryonic stem cells, lack of adequate infrastructure in emerging countries, and difficulties related to stem cell preservation are hampering the growth of this market. Also, high costs pertaining to stem cell processing and lack of reimbursements are some major challenges being encountered by the key players in this market. The global stem cells market can be categorized based on products, applications and technology. Based on products, the global stem cells market is divided into induced pluripotent stem cells, human embryonic stem cells, very small embryonic-like stem cells, adult stem cells, and rat neural stem cells. Adult stem cells that include neuronal stem cells, mesenchymal stem cells, dental stem cells, hematopoietic stem cells, and umbilical cord stem cells, commanded the largest share in this market.
Based on technology, the stem cells market is divided into cryopreservation, expansion production, stem cell acquisition, and sub-culture. The largest and most rapidly growing market segment in this category is stem cell acquisition. This further includes umbilical cord blood, and apheresis, and bone marrow harvesting. Based on application, the stem cells market is divided into drug discovery, regenerative medicine and development. Regenerative medicine commands the largest share in the global stem cells market. This sector covers major therapeutic areas such as hematology, orthopedics, diabetes, incontinence, wound care, oncology, spinal cord injuries, cardiovascular, neurology, and liver disorders.
Based on regions, the global stem cells market is divided into North America, Europe, Asia- Pacific, Middle East and Africa (MEA), and Latin America. Currently, the North American market commands the largest share of the global market followed by Europe. Factors such as increased prevalence of cardiac and neurological diseases, provision of funds from several organizations, intense research activities, and development of new therapies are boosting the growth of this market. However, the Asia-Pacific market is expected to witness a rapid growth over the future years owing to rising number of contract research outsourcing and budding medical tourism industry.
Some of the major companies included in stem cells market report are Advanced Cell Technology, Osiris Therapeutics, Bioheart, Cellartis AB, Biotime Inc., Cellular Engineering Technologies, Angel Biotechnology, Brainstorm Cell Therapeutics, Cytori Therapeutics Inc., California Stem Cell Inc., Stemcell Technologies Inc., and Celgene Corporation Inc.
Market by Products
· Induced pluripotent stem cells
· Human embryonic stem cells
· Very small embryonic-like stem cells
· Adult stem cells
· Rat neural stem cells
Market by Application
· Drug discovery
· Regenerative medicine and development
Market by Technology
· Expansion production
· Stem cell acquisition
Market by Geography
· North America
o Rest of Europe
o Rest of Asia-Pacific
· Latin America
o Rest of Latin America
· Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o Rest of MEA
Introduction The global Hemophilia market is estimated to hit nearly USD 17 billion by 2026. The hemophilia market islikely to grow with 5.3% CAGR during the forecast years. Market Dynamics The increasing initiatives at the global level to create awareness about hemophilia dr
Introduction The global angiography devices Market is projected to worth $16.1 Billion by 2026 and the market is projected to showcase 6.3% CAGR during the forecast period. The angiography devices market is driven by the continuous development in imaging technology for various applications in the healthcare industry. Mar
Introduction Diagnostic ultrasound is an ultrasound application based method. Diagnostic ultrasound technique is used to create an image of structures of internal body such as muscles, blood vessels, tendons, joints and other internal organs. Its aim is to exclude pathology or find a source of a disease. Diagnostic ultrasound is also used for examining pregnant women. The report provides analysis of global
Introduction Breast implants are medical devices that are used to enlarge the size of breasts either for cosmetic applications or rebuilding purpose. Breast expansion, generally called as breast enlargement, is a popular surgical method that enhances the shape and size of the breast. This method includes the use of breast implants in order to improve the size of the breasts. In clinical terms, breast expan
Introduction The global urology devices Market is projected worth US$57.4 billion by 2026 and the market is projected to showcase 6.9% CAGR during the forecast period. The urology devices market is driven by the easy availability of urology devices and high occurrence of urology disorder associated with the urinary tract system (UTS) across the globe.
Introduction The global pet cancer therapeutics Market is projected worth US$345.2 million by 2026 and the market is projected to showcase 10.6% CAGR during the forecast period. The pet cancer therapeutics market is driven by the rapid adoption of innovative pet care medicines. Market Dynamics